Goto M, Johansson H, Maeda A, Elgue G, Korsgren O, Nilsson B
Department of Radiology, Oncology and Clinical Immunology, Division of Clinical Immunology, Rudbeck Laboratory, University Hospital, Uppsala, Sweden.
Transplant Proc. 2004 May;36(4):1186-7. doi: 10.1016/j.transproceed.2004.04.028.
One of the main obstacles to clinical application of islet xenotransplantation is the injurious inflammatory reaction elicited by porcine islets when they are exposed to fresh human blood in vitro and in vivo. This instant blood-mediated inflammatory reaction (IBMIR) causes rapid binding of platelets to the islet surface, activation of the coagulation and complement systems, and leukocyte infiltration of the islets. As a consequence of IBMIR, morphological destruction of porcine islets occurs within the first few hours after transplantation.
In the present study, by analyzing the plasma samples and performing immunohistochemical investigation, we assessed the effect of adding low-molecular weight dextran sulfate (LMW-DS) at 0.01-1 mg/mL to an in vitro tubing loop assay in which porcine islets were exposed to fresh human blood. The effect of LMW-DS also was investigated in an in vivo model using diabetic athymic mice, which provides an innate inflammatory milieu without influence of T cells. The possible toxicity of LMW-DS was assessed by culturing pig islets in the presence or absence of LMW-DS for 3 days.
In the in vitro study, in the presence of LMW-DS at 0.01 mg/mL, platelet consumption, coagulation, and complement activation were reduced, and, at 0.1 mg/mL, LMW-DS totally prevented IBMIR. Immunohistochemical investigation showed that leukocyte infiltration was totally abrogated at the highest dose. A similar finding was observed in the in vivo study. No adverse effect of LMW-DS was observed on the quality of the islets.
LMW-DS appears to be an effective drug candidate that is able to control the strong innate immune response induced by pig islets in contact with human blood.
胰岛异种移植临床应用的主要障碍之一是猪胰岛在体内外接触新鲜人血时引发的有害炎症反应。这种即时血液介导的炎症反应(IBMIR)导致血小板迅速黏附于胰岛表面,激活凝血和补体系统,并使白细胞浸润胰岛。由于IBMIR,猪胰岛在移植后的最初几个小时内就会发生形态破坏。
在本研究中,通过分析血浆样本并进行免疫组织化学研究,我们评估了在体外管路循环试验中添加0.01 - 1 mg/mL低分子量硫酸葡聚糖(LMW-DS)的效果,该试验中猪胰岛暴露于新鲜人血。还在使用糖尿病无胸腺小鼠的体内模型中研究了LMW-DS的作用,该模型提供了无T细胞影响的先天性炎症环境。通过在有或无LMW-DS的情况下培养猪胰岛3天来评估LMW-DS的潜在毒性。
在体外研究中,存在0.01 mg/mL的LMW-DS时,血小板消耗、凝血和补体激活减少,而在0.1 mg/mL时,LMW-DS完全阻止了IBMIR。免疫组织化学研究表明,在最高剂量下白细胞浸润完全消除。在体内研究中也观察到了类似的结果。未观察到LMW-DS对胰岛质量有不良影响。
LMW-DS似乎是一种有效的候选药物,能够控制猪胰岛与人类血液接触所诱导的强烈先天性免疫反应。